NCT06637163 Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC Status RECRUITING Phase PHASE2
NCT06602843 Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy Status RECRUITING Phase NA
NCT06601309 Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC Status RECRUITING Phase PHASE2
NCT06588335 BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06576973 Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06563869 Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE3
NCT06561178 Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401) Status RECRUITING Phase N/A
NCT06560645 A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation Status TERMINATED Phase PHASE1
NCT06549816 A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT06510660 Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC Status RECRUITING Phase PHASE2
NCT06509568 Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma(CRIS-2 Trial) Status RECRUITING Phase PHASE2
NCT06508229 Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC Status NOT_YET_RECRUITING Phase PHASE2
NCT06491134 Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE1
NCT06490003 Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma Status RECRUITING Phase N/A
NCT06487702 A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06468670 Short-course Radiotherapy Combined With Sintilimab for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06468644 Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06463834 A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06446726 Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06429865 Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma Status ENROLLING_BY_INVITATION Phase NA